MiMedx Group, Inc MDXG
4.67
(0.04)
(0.85%)
as of 25 Sep
- Market cap
- $686.5M
- P/E
- 117×
Follow MDXG
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
24.93 | 20.52 | 18.81 | 96.25 |
P/S ratio |
2.63 | 2.39 | 1.51 | 1.60 | |
P/FCF ratio |
15.47 | 13.71 | 8.46 | 12.81 | |
P/Operating CF |
35.23 | 40.09 | 312.06 | (56.82) | |
P/B ratio |
4.32 | 3.90 | 2.41 | 2.63 | |
Price to Tangible BV |
4.96 | 4.49 | 2.79 | 3.08 | |
EV/Sales |
2.31 | 2.04 | 1.14 | 1.27 | |
EV/EBITDA |
13.27 | 10.82 | 8.40 | 22.07 | |
EV/Operating CF |
13.41 | 11.52 | 6.29 | 9.76 | |
EV/FCF |
13.61 | 11.68 | 6.41 | 10.14 | |
Quick Ratio |
3.82 | 3.76 | 4.62 | 4.60 | |
Current Ratio |
4.41 | 4.32 | 5.39 | 5.33 | |
Net Debt/EBITDA |
(4.51) | (6.10) | 9.85 | 7.01 | |
Debt/Assets |
5.71% | 5.24% | 5.70% | 6.12% | |
Debt/Equity |
0.08 | 0.07 | 0.07 | 0.08 | |
Asset Turnover |
1.40 | 1.38 | 1.34 | 1.24 | |
Operating CF/Net income |
1.75 | 1.64 | (0.17) | 0.67 | |
Capex/Depreciation |
(0.04) | (0.08) | (0.40) | (0.41) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.26% | 4.03% | 7.02% | 4.31% | |
Selling, General and Administrative Expense of Revenue |
60.67% | 61.88% | 90.24% | 92.88% | |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.11 | 0.11 | |
Share Based Compensation of Revenue |
4.33% | 2.09% | (2.88%) | 1.40% | |
Graham Net Nets |
0.17 | 0.19 | 0.30 | 0.25 | |
Graham Number |
3.19 | 3.59 | 2.78 | 1.15 | |
Earnings Yield |
4.01% | 4.87% | 5.32% | 1.04% | |
Free Cash Flow Yield |
6.47% | 7.29% | 11.82% | 7.81% | |
Revenue per Share |
0.77 | 0.80 | 0.40 | 0.44 | |
Operating CF per Share |
0.20 | 0.17 | 0.01 | (0.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.20 | 0.17 | 0.01 | (0.07) | |
Cash per Share |
0.96 | 1.12 | 1.08 | 0.92 | |
Shareholders Equity per Share |
1.61 | 1.74 | 1.64 | 1.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.61 | 1.74 | 1.64 | 1.46 | |
Free Cash Flow |
29.14 | 24.71 | 1.24 | (10.65) | |
Working Capital |
196.41 | 213.21 | 195.78 | 166.87 | |
Capital Expenditures |
(0.19) | (0.25) | (0.64) | (0.63) | |
Net Current Asset Value |
174.05 | 191.37 | 174.59 | 140.37 | |
EV/EBIT |
16.88 | 13.34 | 11.22 | 51.47 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Net Profit Margin |
14.73% | 12.86% | (18.41%) | (23.06%) | |
Price to Operating Income |
19.18 | 15.66 | 14.81 | 65.02 | |
| Other line items | |||||
Average Receivables |
66.11 | 65.77 | 54.16 | 55.26 | |
Average Payables |
9.17 | 10.97 | 10.17 | 8.40 | |
Average Inventory |
25.38 | 24.57 | 25.15 | 22.91 | |
Average Assets |
281.44 | 303.28 | 289.55 | 286.05 | |
Average Common Equity |
209.98 | 224.83 | 222.86 | 216.31 |
Columns are period end dates